Tazarotene

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 73473-310
  • Package NDC 73473-310-10
  • Package NDC 73473-310-30
  • Application number ANDA213644
  • SPL ID d0c2fbdf-c1f1-43de-93ef-7da5e6279875
  • SPL set ID f1c98c4a-f101-4f3c-851a-39c827415c46
  • UNII 81BDR9Y8PS
  • RxCUI 313199
  • RxCUI 313201

What the source publishes

Labeler
Solaris Pharma Corporation
Active ingredients
Tazarotene
Form
GEL
Routes
CUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:73473-310_d0c2fbdf-c1f1-43de-93ef-7da5e6279875
{
  "name": "Tazarotene",
  "splId": "d0c2fbdf-c1f1-43de-93ef-7da5e6279875",
  "labels": [
    {
      "setId": "f1c98c4a-f101-4f3c-851a-39c827415c46",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1c98c4a-f101-4f3c-851a-39c827415c46",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f1c98c4a-f101-4f3c-851a-39c827415c46"
    }
  ],
  "routes": [
    "CUTANEOUS"
  ],
  "labeler": "Solaris Pharma Corporation",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 TUBE in 1 CARTON (73473-310-10)  / 100 g in 1 TUBE",
      "package_ndc": "73473-310-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250103"
    },
    {
      "sample": false,
      "description": "1 TUBE in 1 CARTON (73473-310-30)  / 30 g in 1 TUBE",
      "package_ndc": "73473-310-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250103"
    }
  ],
  "productId": "73473-310_d0c2fbdf-c1f1-43de-93ef-7da5e6279875",
  "useDomain": "unknown",
  "dosageForm": "GEL",
  "productNdc": "73473-310",
  "deaSchedule": null,
  "genericName": "Tazarotene",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "TAZAROTENE",
      "strength": "1 mg/g"
    }
  ],
  "applicationNumber": "ANDA213644",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20250103",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175607",
      "M0018962"
    ],
    "unii": [
      "81BDR9Y8PS"
    ],
    "rxcui": [
      "313199",
      "313201"
    ],
    "spl_set_id": [
      "f1c98c4a-f101-4f3c-851a-39c827415c46"
    ],
    "pharm_class_cs": [
      "Retinoids [CS]"
    ],
    "pharm_class_epc": [
      "Retinoid [EPC]"
    ],
    "manufacturer_name": [
      "Solaris Pharma Corporation"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:73473-310_d0c2fbdf-c1f1-43de-93ef-7da5e6279875"